DISCOUNT OPTIONSSCHEIN - AMGEN | Market Closed - Börse Stuttgart 12:19:15 11/05/2024 am IST | ||
| 1.56 EUR | -4.29% |
|
| Current month | +27.87% | ||
| 1 month | +9.86% |
Comparison chart between the derivative product and it's underlying value
End-of-day quotes
Chart
AMGEN INC.
Latest news about AMGEN INC.
More news
| Date | Price | Change | Volume |
|---|---|---|---|
| 10/24/10 | 1.56 | -4.29% | 0 |
| 09/24/09 | 1.63 | +7.95% | 0 |
| 08/24/08 | 1.51 | +4.86% | 0 |
| 07/24/07 | 1.44 | +3.60% | 0 |
| 06/24/06 | 1.39 | -33.81% | 0 |
Delayed Quote Börse Stuttgart
Last update May 11, 2024 at 12:19 am IST
More quotesStatic data
| Product type | Exotic Products |
|---|---|
| Buy / Sell | CALL |
| Underlying | AMGEN INC. |
| Issuer | Morgan Stanley |
| WKN | ME81JH |
| ISIN | DE000ME81JH8 |
| Date issued | 01/02/2024 |
| Strike | 390 $ |
| Maturity | 20/09/2024 (132 Days) |
| Parity | 1 : 1 |
| Emission price | 1.69 € |
| Emission volume | N/A |
| Settlement | cash |
| Currency | EUR |
Technical Indicators
| Highest since issue | 3.95 € |
|---|---|
| Lowest since issue | 0.97 € |
Company Profile
Amgen Inc. is one of the world's leading biotechnology groups. Net sales break down by source of revenue as follows:
- drug sales (94.2%): drugs for treating cancer, metabolic disorders, bone diseases, renal failure, hemophilia, etc.;
- other (5.8%): primarily royalties.
The United States account for 70.3% of net sales.
Sector
-
Consensus: Amgen Inc.
Sell
Buy
Mean consensus
OUTPERFORM
Number of Analysts
30
Last Close Price
310.2
USD
Average target price
314.6
USD
Spread / Average Target
+1.45%
- Stock Market
- Certificates
- Certificat